Combined treatment of murine leukemia P388 with doxorubicin and platinum(IV)-nitroxyl complex ВС118 administered in low doses improved efficiency of treatment (cure of 83% of animals) without increasing toxicity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Goncharova SA, Rajewskaya TA, Yakushenko TN, Blokhina SV, Konovalova NP, Senj VD. Antileukemic activity and development of resistance to cisplatin (CPT) and platinum (IV)-nytroxyl complex VS118. Vopr. Onkol. 2011;57(3):355-358. Russian.
Goncharova SA, Raevskaya TA, Yakushchenko TN, Blokhina SV, Konovalova NP, Sen’ VD. Synergistic antitumor effect of cisplatin and the platinum(IV) nitroxyl complex BC118 and the development of resistance to their combined action. Rus. Chem. Bull. 2011;60(9):1944-1947.
Korman DB. Targets and Mechanisms of Action of Anticancer Drugs. Moscow, 2014. Russian.
Mumyatova VA, Balakina AA, Lapshina MA, Sen’ VD, Kornev AB, Terent’ev AA. Influence of Tumor Suppressor p53 Functioning on the Expression of Antioxidant System Genes under the Action of Cytotoxic Compounds. Bull. Exp. Biol. Med. 2020;169(1):169-175. doi: https://doi.org/10.1007/s10517-020-04844-3
Manual on Chemotherapy of Tumors. Perevodchikova NI, ed. Moscow, 2017. Russian.
Manual for Preclinical Studies of New Pharmacological Substances. Part I, Mironov AN, ed. Moscow, 2012. Russian.
Barenholz YC. Doxil® — the first FDA-approved nano-drug: lessons learned. J. Control. Release.2012;160(2):117-134.doi: https://doi.org/10.1016/j.jconrel.2012.03.020
Mizutani H, Tada-Oikawa S, Hiraku Y, Kojima M, Kawanishi S.Mechanism of apoptosisinduced by doxorubicin through the generation of hydrogem peroxide. Life Sci. 2005;76(13):1439-1453.doi: https://doi.org/10.1016/j.lfs.2004.05.040
Monti E, Cova D, Guido E, Morelli R, Oliva C. Protective effect of the nitroxidetempol against the cardiotoxicity of Adriamycin. Free Radic. Biol. Med. 1996;21(4):463-470. doi: https://doi.org/10.1016/0891-5849(96)00124-4
Pugazhendhi A, Edison TNJI, Velmurugan BK, Jacob JA, Karuppusamy I. Toxicity of doxorubicin (doxorubicin) to different experimental organ systems. Life Sci. 2018;200:26-30. doi: https://doi.org/10.1016/j.lfs.2018.03.023
Schoch S, Sen V, Gajewski S, Golubev V, Strauch B, Hartwig A, Köberle B. Activity profile of the cisplatin analogue PN149 in different tumor cell lines. Biochem. Pharmacol. 2018;156:109-119. doi: https://doi.org/10.1016/j.bcp.2018.08.025
Sen’ VD, Terentyiev AA, Konovalova NP. Platinum complexes with bioactive nitroxyl radicals: synthesis and antitumor properties. Nitroxides — theory, experiment and applications. Kokorin A, ed. InTech, 2012. P. 385-406.doi: https://doi.org/10.5772/39113
Sen’ VD, Tkachev VV, Volkova LM, Goncharova SA, Raevskaya TA, Konovalova NP. Synthesis, structure, and antitumor properties of platinum(IV) complexes with aminonitroxyl radicals. Russ. Chem. Bull. 2003;52(2):421-426. doi: https://doi.org/10.1023/A:1023475319835
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 171, No. 3, pp. 323-327, March, 2021
Rights and permissions
About this article
Cite this article
Goncharova, S.A., Raevskaya, T.A., Klimanova, E.N. et al. The Increase of Antileukemic Efficiency of Doxorubicin and Other Cytostatics Combined with Platinum(IV)-Nitroxyl Complex ВС118. Bull Exp Biol Med 171, 342–346 (2021). https://doi.org/10.1007/s10517-021-05224-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-021-05224-1